Genomic Health, Inc. (GHDX) Misses Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Genomic Health, Inc. (NASDAQ: GHDX) reported Q1 EPS of ($0.24), $0.06 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $67 million versus the consensus estimate of $68.47 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Mizuho Downgrades Edison International (EIX) to Neutral
- Baird Upgrades CNH Industrial (CNH) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
